Schmidt LJ - Search Results

1

Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.

Schmidt LJ, Regan KM, Anderson SK, Sun Z, Ballman KV, Tindall DJ. Schmidt LJ, et al. Prostate. 2009 Dec 1;69(16):1730-43. doi: 10.1002/pros.21022. Prostate. 2009. PMID: 19676081 Free PMC article.

2

Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride.

Schmidt LJ, Murillo H, Tindall DJ. Schmidt LJ, et al. J Androl. 2004 Nov-Dec;25(6):944-53. doi: 10.1002/j.1939-4640.2004.tb03166.x. J Androl. 2004. PMID: 15477368 Free article.

3

Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence.

Murillo H, Schmidt LJ, Karter M, Hafner KA, Kondo Y, Ballman KV, Vasmatzis G, Jenkins RB, Tindall DJ. Murillo H, et al. Among authors: schmidt lj. Genes Chromosomes Cancer. 2006 Jul;45(7):702-16. doi: 10.1002/gcc.20333. Genes Chromosomes Cancer. 2006. PMID: 16615098

4

Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.

Schmidt LJ, Ballman KV, Tindall DJ. Schmidt LJ, et al. Prostate. 2007 Jul 1;67(10):1111-20. doi: 10.1002/pros.20602. Prostate. 2007. PMID: 17477363

5

Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.

Dehm SM, Regan KM, Schmidt LJ, Tindall DJ. Dehm SM, et al. Among authors: schmidt lj. Cancer Res. 2007 Oct 15;67(20):10067-77. doi: 10.1158/0008-5472.CAN-07-1267. Cancer Res. 2007. PMID: 17942941

6

Androgen modulation of coregulator expression in prostate cancer cells.

Heemers HV, Regan KM, Schmidt LJ, Anderson SK, Ballman KV, Tindall DJ. Heemers HV, et al. Among authors: schmidt lj. Mol Endocrinol. 2009 Apr;23(4):572-83. doi: 10.1210/me.2008-0363. Epub 2009 Jan 22. Mol Endocrinol. 2009. PMID: 19164447 Free PMC article.

7

Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.

Wang D, Montgomery RB, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ. Wang D, et al. Among authors: schmidt lj. Cancer Res. 2009 Dec 15;69(24):9448-56. doi: 10.1158/0008-5472.CAN-09-1903. Cancer Res. 2009. PMID: 19934328 Free PMC article.

8

Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.

Heemers HV, Schmidt LJ, Kidd E, Raclaw KA, Regan KM, Tindall DJ. Heemers HV, et al. Among authors: schmidt lj. Prostate. 2010 Jun 15;70(9):959-70. doi: 10.1002/pros.21130. Prostate. 2010. PMID: 20166126 Free PMC article.

9

Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.

Schmidt LJ, Tindall DJ. Schmidt LJ, et al. J Steroid Biochem Mol Biol. 2011 May;125(1-2):32-8. doi: 10.1016/j.jsbmb.2010.09.003. Epub 2010 Sep 29. J Steroid Biochem Mol Biol. 2011. PMID: 20883781 Review.

10

RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.

Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV. Schmidt LJ, et al. Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28. Mol Endocrinol. 2012. PMID: 22456196 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters